Hostname: page-component-7c8c6479df-xxrs7 Total loading time: 0 Render date: 2024-03-30T04:55:47.210Z Has data issue: false hasContentIssue false

Hospital Costs in Patients with Nosocomial Methicillin-Resistant or Methicillin-Susceptible Staphylococcus aureus Bloodstream Infection

Published online by Cambridge University Press:  02 January 2015

Dominique M. Vandijck*
Affiliation:
Department of Public Health and Health Economy, Ghent University, Ghent, Belgium Department of General Internal Medicine and Infectious Diseases, Ghent University Hospital, Ghent, Belgium
Lieven Annemans
Affiliation:
Department of Public Health and Health Economy, Ghent University, Ghent, Belgium
Dirk P. Vogelaers
Affiliation:
Department of General Internal Medicine and Infectious Diseases, Ghent University Hospital, Ghent, Belgium Department of Healthcare, University College Ghent, Ghent, Belgium
Stijn I. Blot
Affiliation:
Department of General Internal Medicine and Infectious Diseases, Ghent University Hospital, Ghent, Belgium Department of Healthcare, University College Ghent, Ghent, Belgium
*
Faculty of Medicine and Health Sciences, Department of Public Health and Health Economy, Ghent University, De Pinteiaan 185, 9000 Ghent, Belgium (dominique.vandijck@ugent.be)
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

References

1.Vandijck, DM, Blot, SI, Decruyenaere, JM, et al.Costs and length of stay associated with antimicrobial resistance in acute kidney injury patients with bloodstream infection. Acta Clin Belg 2008;63:3138.CrossRefGoogle ScholarPubMed
2.Vandijck, DM, Depaemelaere, M, Labeau, SO, et al.Daily cost of antimicrobial therapy in patients with intensive care unit-acquired, laboratory-confirmed bloodstream infection. Int J Antimicrob Agents 2008;31:161165.CrossRefGoogle ScholarPubMed
3.Ben-David, D, Novikov, I, Mermel, LA. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection? Infect Control Hosp Epidemiol 2009;30:453460.CrossRefGoogle ScholarPubMed
4.Depuydt, PO, Vandijck, DM, Bekaert, MA, et al.Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit Care 2008;12:R142. http://ccforum.com/content/12/6/R142. Published November 17, 2008. Accessed November 17, 2008.Google Scholar
5.Vandijck, DM, Blot, SI, Labeau, SO, et al.Candidemia in critically ill patients: an analysis of daily antifungal therapy related costs. J Mycol Med 2008;18:9699.CrossRefGoogle Scholar
6.Shurland, SM, Stine, OC, Venezia, RA, et al.Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilities. Infect Control Hosp Epidemiol 2009;30:313318.CrossRefGoogle ScholarPubMed
7.Hoste, EA, Vandijck, DM, Van Holder, RC, et al.Health implications of antimicrobial resistance for patients with acute kidney injury and bloodstream infection. Infect Control Hosp Epidemiol 2007;28:11071110.CrossRefGoogle ScholarPubMed
8.Iosifidis, E, Antachopoulos, C, Tsivitanidou, M, et al.Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece. Infect Control Hosp Epidemiol 2008;29:615622.CrossRefGoogle Scholar
9.Blot, S, Depuydt, P, Vandewoude, K, De Bacquer, D. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis 2007;20:391396.CrossRefGoogle ScholarPubMed